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ABSTRACT To compare clinical (non-invasive) diagnosis with bronchoscopic (invasive) diagnosis, a 
total of 50 patients with chronic pneumonia (sputum smear-negative for tuberculosis) were examined. 
Age range was 12–82 years. Sensitivity of clinical diagnosis was 100% for tuberculosis and 81.8% for 
lung cancer; specificity was 67.5% for tuberculosis and 89.7% for lung cancer. Clinical diagnosis was 
correct in 43.4% of cases suspected of tuberculosis and 69.2% of cases suspected of lung cancer. It 
may be reliable only for elderly women smokers. Because tuberculosis is over-diagnosed in endemic 
areas, bronchoscopy is strongly recommended for all cases of chronic pneumonia. 
Spécificité et sensibilité du diagnostic clinique pour la pneumonie chronique
RÉSUMÉ Afin de comparer le diagnostic clinique (non invasif) avec le diagnostic bron-
choscopique (invasif), un effectif total de 50 patients souffrant de pneumonie chronique (frottis 
d’expectoration négatif pour la tuberculose) a été examiné. L’âge des patients était compris entre 12 et 
82 ans. La sensibilité du diagnostic clinique était de 100 % pour la tuberculose et de 81,8 % pour le 
cancer du poumon ; la spécificité était de 67,5 % pour la tuberculose et de 89,7 % pour le cancer du 
poumon.  Le diagnostic clinique était correct dans 43,4 % des cas suspects de tuberculose et dans 
69,2 % des cas suspects de cancer du poumon.  Il peut être fiable uniquement pour les femmes âgées 
qui fument. Étant donné que la tuberculose est surdiagnostiquée dans les zones d’endémie, la bron-
choscopie est fortement recommandée pour tous les cas de pneumonie chronique.
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Introduction
Diagnosis of pneumonia is predominantly a 
clinical diagnosis. Signs and symptoms of 
lower respiratory tract infection are, how-
ever, not unique to pneumonia [1]. Pneu-
monia that fails to resolve at the expected 
rate, e.g. when the radiograph has failed to 
resolve by 50% in 2 weeks, or completely in 
4 weeks [2,3], or does not show signiﬁcant 
radiographic resolution after at least 10 days 
of antibiotic therapy [4,5], is considered to 
be chronic pneumonia [3–5], a diagnosis 
which to many clinicians conjures up an as-
sociation with underlying neoplasm or less 
common pathogens [6].
The cause of non-resolving pneumonias 
may be non-infectious or infectious and 
usually invasive diagnostic techniques are 
required for conﬁrmation [7,8]. It remains 
controversial to decide when to initiate an 
invasive diagnostic work-up for chronic in-
ﬁltrates [9]. When clinical improvement has 
not occurred and chest radiographs remain 
unchanged or worsen, or in a situation with 
patients who are clinically stable or impro-
ving when the rate of radiographic resolu-
tion is delayed, then a more aggressive 
approach is warranted [9].
Fibreoptic bronchoscopy (FOB), which 
has minimal morbidity, is the preferred 
initial invasive method [7] and as the ﬁrst 
step in the evaluation of non-resolving 
pneumonias after an appropriate period of 
observation [4,10–12]. 
In some conditions there is a long time 
between the initial and ﬁnal diagnosis of 
chronic pneumonia, which usually occurs 
after failure of treatment for tuberculosis or
lung cancer. Because many chronic pneu-
monia patients are treated by general prac-
titioners in the absence of a diagnosis, it 
is important that they have knowledge of 
the sensitivity and speciﬁcity of clinical 
diagnosis for chronic pneumonia as they are 
the ones who gene-rally make the primary 
diagnosis.
In reality, very little is known regarding 
the sensitivity and speciﬁcity of clinical di-
agnosis. In other words, how sensitive and 
speciﬁc is this method of diagnosis? Is it 
reliable? When should an invasive method 
of diagnosis be requested? These questions 
need to be answered. It is important that 
the reliability of the non-invasive method 
is assessed, particularly for tuberculosis. 
Additionally, it has been recommended that 
FOB be performed early in heavy smokers 
and patients > 50 years of age with slow 
or non-resolving pneumonia [5]. The aim 
of this study was, therefore, to compare 
the primary or clinical diagnosis with ﬁnal 
diagnosis done by FOB and to ﬁnd out how 
well matched they were.
Methods
This study was conducted in the infectious 
and tropical diseases clinic and ward of 
Al-Zahra Hospital, which is afﬁliated to Is-
fahan University of Medical Sciences, with 
the cooperation of the pulmonology, radio-
logy and pathology departments. Al-Zahra 
Hospital is a specialty and sub-specialty 
hospital which is equipped with the latest 
modern facilities. An evaluation study was 
carried out from January 2004 to June 2004 
on 50 patients who were examined using 
FOB because of non-resolving pneumonia. 
Many patients treated in private clinics 
of our infectious diseases clinic with acute 
presentation of pneumonia failed to respond 
to treatment. They were then referred by 
their physicians to the pulmonology unit for 
bronchoscopy. 
Inclusion criteria for this study were: 
non-resolved signs and symptoms (cough 
or sputum) despite at least 10 days antibi-
otic therapy against community acquired 
 ٢٠٠٥ ،٦-٥ ﺪﻌﻟ ،ﺮﺸﻋ Eﺎﳊ ﺪﻠﺠﳌ ،ﺔﻴﳌﺎﻌﻟ ﺔﺤﺼﻟ ﺔﻤﻈﻨﻣ ،ﻂﺳﻮﺘﳌ Lﺮﺸﻟ ﺔﻴﺤﺼﻟ ﺔﻠﺠﳌ
Eastern Mediterranean Health Journal, Vol. 11, Nos 5/6, 2005 1031
pneumonia [3–5]; lung inﬁltration in chest 
X-ray for at least 2 weeks (indicated in 2 
chest X-rays); and negative sputum smear 
for tuberculosis.
There were many patients with acute 
presentation of pneumonia such as fever, 
cough, sputum and lobar or segmental 
inﬁltration of the chest X-ray who had been 
diagnosed and treated as acute community 
acquired pneumonia. The usual treatment 
regimen was ceftriaxon 1 g every 12 hours 
for 10 days plus erythromycin 400 mg every 
6 hours for 10 days. Patients who showed 
no clinical response (continuous fever, spu-
tum and cough) were re-evaluated. At this 
stage any patients having the ﬁrst criteria 
were sent for a second chest X-ray (second 
criteria) and they were also referred to the 
reference laboratory for tuberculosis in 
Isfahan to exclude tuberculosis by sputum 
smear (× 3) (third criteria).
The exclusion criteria were: patients 
with deﬁnitive diagnosis; testing positive 
for human immunodeﬁciency virus (HIV); 
patients without previous chest X-rays 
(at least 2 X-rays are needed to conﬁrm 
chronic pneumonia); patients with previous 
bronchoscopy; and patients who did not 
have a complete history taken and had not 
had a physical examination.
We selected 50 patients consecutively 
during the period January 2004–June 2004 
who had been diagnosed with chronic 
pneumonia and who met the inclusion and 
exclusion criteria. There were about 70 pa-
tients who did not meet the criteria, mainly 
not showing lung inﬁltration in 2 chest 
X-rays. All of the patients who were 
selected for the study were informed and 
completed a consent form. There were no 
refusals to participate.
The data collected included information 
obtained from the patient, demographic 
characteristics, chief complaints, course 
and duration of symptoms, history of smo-
king (packs per year), previous underlying 
disease, previous therapy and management 
recorded on the base of declarations of 
patients. Data regarding clinical diagnosis 
(non-invasive method) was based on the 
ﬁrst diagnosis of the infectious diseases 
specialist (history taking, physical examina-
tion). The ﬁndings of chest X-ray (postero-
anterior and lateral) were recorded from the 
radiologist’s report.
All patients had 3 negative sputum 
smears for acid-fast bacilli. The clinical 
diagnosis (non-invasive method) was 
based on the ﬁrst diagnosis of an infectious 
diseases specialist (history taking, physical 
examination), report and suggestion of a 
radiologist for 2 chest X-rays. In this step, 
according to this diagnosis, all patients 
were classiﬁed as: tuberculosis, lung cancer 
or others (bronchectasia, chronic bronchi-
tis, aspiration pneumonia and non-speciﬁc 
diagnosis). 
All patients were then examined by FOB 
for a deﬁnitive diagnosis. In this study, FOB 
diagnosis (invasive method), which was 
conducted by a pulmonologist in the pul-
monology unit of the hospital, was the gold 
standard. It included all procedures done by 
FOB: bronchial washing, bronchial biopsy, 
bronchial brushing, bronchoalveolar lavage 
and transbronchial biopsy. The samples 
obtained by FOB were sent to the hospital 
laboratory for cytological analysis and to 
the reference laboratory for tuberculosis 
in Isfahan for direct smear and culture for 
acid-fast bacilli.
All acid-fast bacilli sputum smears or 
cultures positive in the bronchoalveolar 
lavage procedure were classiﬁed as having 
tuberculosis. Patients with positive ﬁndings 
indicating cancer (cytology) in bronchoal-
veolar lavage were classiﬁed as having lung 
cancer. 
Patients were divided into 2 groups by 
history of smoking: non-smokers or light 
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smokers (≤ 40 packs per year) and heavy 
smokers (> 40 packs per year) [5].
Statistical analysis was performed 
using the binominal test to compare data for 
each method of diagnosis. The chi-squared 
test was used to compare the results of sex 
difference and type of smoking and also 
Fisher’s exact test to compare the results for 
age group (≤ 50 years and > 50 years) using 
SPSS, version 11. The level of signiﬁcance 
was P < 0.05.
Results
The study sample included 23 males and 
27 females (male to female ratio 0.85:1) 
(Table 1). In terms of age, 78% were > 50 
years and 8% were ≤ 30 years. Mean (stan-
dard deviation) age was 57 (20.1) years for 
men and 66 (15.4) years for women.
The main clinical diagnoses for these 
patients with chronic pneumonia were 
tuberculosis (23 patients) and lung cancer 
(13 patients) (Table 2).
Of the 23 patients who had a clinical 
diagnosis of tuberculosis, only 10 were 
conﬁrmed by FOB (Table 3). Clinical di-
agnosis of not having tuberculosis was the 
same. Only 9 of the 13 patients clinically 
diagnosed with lung cancer were conﬁrmed 
by FOB (Table 4). Two of those diagnosed 
as not having lung cancer were eventually 
diagnosed with the disease and were added 
to lung cancer category but they are not in 
the group diagnosed by clinical diagnosis.
So in 23 out of 50 patients, positive 
diagnosis of using the non-invasive method 
was as the same as for the invasive method 
of diagnosis. The binominal test indicated 
a highly signiﬁcant difference between the 
invasive and the non-invasive methods of 
diagnosis, indicating that the non-invasive 
method was not a reliable method for 
cases of chronic pneumonia (P < 0.001) 
(Table 2). 
The sensitivity of clinical diagnosis for 
tuberculosis was 100% but speciﬁcity was 
67.5% (Table 3). The sensitivity of clinical 
diagnosis for lung cancer was 81.8% but 
speciﬁcity was 89.7% (Table 4). 
Overall, the correct diagnosis was found 
in 34.7% (8 out of 23) of males by the 
no-ninvasive method of diagnosis, (con-
ﬁrmed by FOB) and 55.5% (15 out of 27) 
of females (Table 5). The difference was 
not signiﬁcant using the chi-squared test 
(P = 0.142). 
Ten of the males (43.4%) and 1 of 
the females (3.7%) (/27) were classed as 
heavy smokers (≥ 40 packs/year). The non-
invasive method produced a correct diagno-
sis in 63.6% of heavy smokers and 41.0% 
of non-smokers or light smokers (Table 6). 
However, the chi-squared test showed the 
difference was not signiﬁcant (P = 0.184). 
The non-invasive method gave the 
correct diagnosis in 27.2% of patients ≤ 50 
years and 48.5% of patients > 50 years. 
Fisher’s exact test showed there was no 
signiﬁcant difference (P = 0.189).
Table 1 Distribution of patients by age and sex
Sex Age (years)
  11–20 21–30 31–40 41–50 51–60 61–70 71–80 > 80 Total
  No. No. No. No. No. No. No. No. No.
Male 2 1 1 3 4 5 6 1 23
Female 0 1 1 2 3 6 11 3 27
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Discussion
The presentation of chronic pneumonia syn-
drome is varied and may mimic neoplasm, 
interstitial lung disease, or chronic fungal or 
mycobacterial infection [6].  
In this study, sensitivity of clinical 
diagnosis for tuberculosis and lung cancer, 
the 2 main diagnoses for patients with 
chronic pneumonia, was high, 100% and 
81.8% respectively. Speciﬁcity of clinical 
diagnosis was lower, especially for tuber-
culosis (67.5%); it was higher for lung 
cancer (89.7%). It must be remembered 
that many of the patients in this study had 
ﬁrst been managed by general practitioners, 
who use clinical diagnosis as the baseline of 
management. This indicates that in endemic 
Table 2 Comparison of non-invasive (clinical) diagnosis and 
invasive diagnosis (fibreoptic bronchoscopy)
Disease Non-invasive  Invasive diagnosis
  diagnosisa Confirmed Ruled out
  No. No. No.
TB 23 10 13a
Lung cancer 13 9 4b
Other   
 Chronic bronchitis 
 or bronchectasia 8 4 4
 Aspiration 
 pneumonia 4 0 4c
 Non-specific 
 diagnosis 2 0 2d
Total 50 23 27
TB = tuberculosis.
P < 0.001.




Table 3 Specificity and sensitivity of clinical diagnosis for 
tuberculosis among chronic pneumonia patients, measured by 
bronchoscopy
Disease Non-invasive  Invasive diagnosis (bronchoscopy)
  diagnosis TB confirmed TB ruled out 
  No. No. No.
TB 23 10 13a
Non-TB 27 0 27
Total 50 10 40
TB = tuberculosis.
a2 of these 13 patients were eventually diagnosed as having lung cancer.
Sensitivity of clinical diagnosis = 10/(10 + 0) = 100%.
Specificity of clinical diagnosis = 27/(27 + 13) = 67.5%.
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areas, clinical diagnosis may give an over-
diagnosis of tuberculosis of up to 32.5%, an 
alarming rate given that in some endemic 
areas FOB is not available and these patients 
are at risk of being wrongly treated.
It is important to differentiate slowly 
resolving from non-resolving pneumonias 
because the cause of each is different. In 
general, slowly resolving pneumonias are 
caused by antimicrobial or host defence 
factors [7] but the cause of non-resolving or 
progressive pneumonia may be infectious or 
non-infectious [8]. Several risk factors have 
been established for delayed radiographic 
resolution of pneumonia and should be con-
sidered in patient evaluation. They include 
coexisting medical conditions, history of 
smoking, advanced age, diabetes mellitus, 
chronic obstructive pulmonary disease and 
conditions that mimic pneumonia (e.g. neo-
plasms) [13]. Some of the patients in this 
study of chronic pneumonia syndrome also 
Table 4 Specificity and sensitivity of clinical diagnosis of lung cancer 
among chronic pneumonia patients measured by bronchoscopy
Disease Non-invasive  Invasive diagnosis (bronchoscopy)
  diagnosis Lung cancer   Lung cancer 
   confirmed ruled out 
  No. No. No.
Lung cancer 13 9 4
Non-lung cancer 37 2a 35
Total 50 11 39
aThese 2 patients were originally diagnosed as having tuberculosis.
Sensitivity of clinical diagnosis = 9/(9 + 2) = 81.8%.
Specificity of clinical diagnosis = 35/(35 + 4) = 89.7%.
Table 5 Comparison of clinical diagnosis (non-invasive) and final 
diagnosis (invasive) by sex
Disease Non-invasive  Invasive diagnosis (bronchoscopy)
  diagnosis Confirmed Ruled out
  No. No. No.
Tuberculosis  23 10 13a
 Male 7 2 5
 Female 16 8 8
Lung cancer 13 9 4
 Male 6 4 2
 Female 7 5 2
Bronchitis 8 4 4
 Male 5 2 3
 Female 3 2 1
Other 6 0 6
 Male 5 0 5
 Female 1 0 1
Total 50 23 27
a2 of these 13 patients were eventually diagnosed as having lung cancer.
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had underlying predisposing conditions, ad-
vanced age (78% > 50 years) and history of 
heavy smoking: more than 20% of patients 
were heavy smokers.
Concerning reliability of clinical diag-
nosis, FOB conﬁrmed the diagnosis made 
by non-invasive methods in no more than 
23 (46.0%) patients. In other words, in 
54.0% of patients in this study the clinician 
had failed to reach a correct diagnosis. 
Could it be a reliable method? There was a 
statistically signiﬁcant difference between 
the non-invasive and the invasive method 
of diagnosis (P < 0.001). So the non-
invasive method of diagnosis was not a 
reliable method for chronic pneumonia syn-
drome. This may result in over-diagnosis of 
tuberculosis and lung cancer.
Non-invasive methods of diagnosis may, 
however, be correct in some circumstances. 
For example, it was correct in 34.7% of 
men and 55.5% of women. It was correct 
in 63.6% of heavy smokers and 41.0% of 
light smokers/non-smokers. It was also 
diagnostic in 48.5% of patients ≥ 50 years 
old. But after statistical analysis, there was 
no signiﬁcant difference. 
Non-resolving or slowly resolving 
pulmonary inﬁltrates constitute a clinical 
diagnostic challenge for physicians [7]. 
Invasive techniques such as FOB with 
bronchoalveolar lavage and appropriate 
culture for bacteria, Legionella spp., fungi, 
and mycobacterium can also be deferred 
when unequivocal, albeit incomplete, ra-
diographic resolution can be demonstrated 
[9]. The technique is extremely useful 
in ﬁnding a speciﬁc diagnosis for a non-
resolving pneumonia (in those cases where 
a speciﬁc diagnosis can be made) [4]. In 
other words, FOB, in the absence of any 
indications, is rarely diagnostic and should 
not be routinely employed [14]; it may be 
required in selected cases for the diagnosis 
of tuberculosis [15]. It should, however, be 
accompanied by bronchoalveolar lavage, 
bronchial washings and post-bronchoscopy 
sputum smears. 
Fibreoptic bronchoscopy procedures 
have provided overall diagnostic yields 
in 5.8% [16], 32.5% [17], 87.1% [18] and 
90% [19] of patients suspected of having 
tuberculosis. In the present study, overall 
Table 6 Comparison of clinical diagnosis (non-invasive) and final 
diagnosis (invasive) by smoking habit
Category  Non-invasive  Invasive diagnosis (bronchoscopy)
  diagnosis Confirmed Ruled out
  No. No. No.
Heavy smokera 11 7 4
 TB 4 2 2
 Lung cancer 5 4 1
 Other 2 1 1
Non-smoker/light 
smokera 39 16 23
 TB 19 8 11
 Lung cancer 8 5 3
 Bronchitis 12 3 9
Total 50 23 27
TB = tuberculosis.
aHeavy smoker: ≥ 40 packs/year; light smoker: < 40 packs per year.
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diagnostic yield was 43.5%. Moreover, lung 
cancer was diagnosed in 2 of the patients 
who were ruled out for tuberculosis. As in a 
previous study, these results suggest that in 
an area with high prevalence of tuberculo-
sis, FOB procedures should be performed in 
patients with chronic pneumonia syndrome 
where other conditions (such as tuberculosis 
or malignancy) must be ruled out [17].
Fibreoptic bronchoscopy may be the 
best means of evaluating the bronchial 
tree and adjacent lung parenchyma [20] 
and bronchoalveolar lavage can provide 
diagnostic information in cases of primary 
and metastatic disease of the lung [21]. 
Bronchoscopic material can be obtained 
in about 50% of primary lung cancers, 
with more accuracy in bronchoalveolar 
cell carcinoma and adenocarcinoma than 
in squamous cell carcinoma [21]. It is most 
useful (73%) in the diagnosis of broncho-
genic carcinoma [12]. Of the 11 lung cancer 
patients in our study, 91% were diagnosed 
as bronchogenic carcinoma and 1 patient as 
adenocarcinoma, a ﬁnding which is similar 
those of some previous studies [12,21].
Bronchoscopic procedures in the sus-
pected cancer cases in this study provided 
overall diagnostic yields in 69.2% (9/13) 
of patients. In 2 patients with suspected tu-
berculosis, this was ruled out and they were 
ﬁnally conﬁrmed as having lung cancer. 
Overall diagnostic yield was 66.7% (10/15). 
These results show the importance of FOB 
in the diagnosis of tuberculosis and lung 
cancer in patients with chronic pneumonia.
To sum up, the sensitivity of the non-
invasive method of diagnosis was 100% 
for pulmonary tuberculosis and 81.8% for 
lung cancer. Speciﬁcity was 67.5% for 
pulmonary tuberculosis and 89.7% for lung 
cancer. Therefore, this method may not be 
reliable, at least for tuberculosis. Also, it 
suggests that FOB is a necessary option 
in every chronic pneumonia patient. In 
fact, as indicated in a previous study, FOB 
must be performed early in heavy smokers 
and patients > 50 years of age with slow or 
non-resolving pneumonia [5]. In contrast, 
in light smokers/non-smokers or younger 
patients, it should only be performed after 
4–8 weeks unless clinical symptoms justify 
an earlier intervention [6].
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